InogenINGN
About: Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Employees: 834
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
115% more call options, than puts
Call options by funds: $2.11M | Put options by funds: $979K
72% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 29
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
2% less funds holding
Funds holding: 133 [Q3] → 130 (-3) [Q4]
5.46% less ownership
Funds ownership: 89.22% [Q3] → 83.76% (-5.46%) [Q4]
11% less capital invested
Capital invested by funds: $205M [Q3] → $183M (-$22.3M) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for INGN.
Financial journalist opinion
Based on 6 articles about INGN published over the past 30 days
